These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 22928276)

  • 41. Building consensus: steps toward standardised haemovigilance reporting.
    Roubinian N; Kleinman S
    Lancet Haematol; 2019 Jul; 6(7):e339-e340. PubMed ID: 31080133
    [No Abstract]   [Full Text] [Related]  

  • 42. The entity of immunoglobulin A-related anaphylactic transfusion reactions is not evidence based.
    Sandler SG; Eder AF; Goldman M; Winters JL
    Transfusion; 2015 Jan; 55(1):199-204. PubMed ID: 25066014
    [No Abstract]   [Full Text] [Related]  

  • 43. Comparing transfusion reaction risks for various plasma products - an analysis of 7 years of ISTARE haemovigilance data.
    Saadah NH; van der Bom JG; Wiersum-Osselton JC; Richardson C; Middelburg RA; Politis C; Renaudier P; Robillard P; Schipperus MR
    Br J Haematol; 2018 Mar; 180(5):727-734. PubMed ID: 29318576
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Pharmacologic alternatives to transfusion.
    Ness PM
    Vox Sang; 2002 Aug; 83 Suppl 1():3-6. PubMed ID: 12617091
    [No Abstract]   [Full Text] [Related]  

  • 45. Transfusion therapy in neonates.
    Strauss RG
    Am J Dis Child; 1991 Aug; 145(8):904-11. PubMed ID: 1858728
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The infectious risks of transfusions in the United States: a decision-analytic approach.
    Heymann SJ; Brewer TF
    Am J Infect Control; 1993 Aug; 21(4):174-82. PubMed ID: 8239047
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Retrospective transfusional audit at the Centro Nacional de la Transfusión Sanguínea].
    Juárez-Rangel E; Vite-Casanova MJ; Marín y López RA; Sánchez-Guerrero SA
    Rev Invest Clin; 2004; 56(1):38-42. PubMed ID: 15144041
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Transfusion hazard reporting: powerful data, but do we know how best to use it?
    Williamson LM
    Transfusion; 2002 Oct; 42(10):1249-52. PubMed ID: 12423506
    [No Abstract]   [Full Text] [Related]  

  • 49. [Universal implementation of pathogen inactivation in labile blood products is a major step towards transfusion safety].
    Cazenave JP
    Bull Acad Natl Med; 2010 Dec; 194(9):1707-19; discussion 1719-20. PubMed ID: 22043595
    [TBL] [Abstract][Full Text] [Related]  

  • 50. How do we implement Day 6 and Day 7 platelets at a hospital-based transfusion service?
    Dunbar NM; Dumont LJ; Szczepiorkowski ZM
    Transfusion; 2016 Jun; 56(6):1262-6. PubMed ID: 27018564
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Respiratory and infectious complications of blood transfusion].
    Wautier MP; Wautier JL
    Rev Prat; 2012 May; 62(5):699-700. PubMed ID: 22730808
    [No Abstract]   [Full Text] [Related]  

  • 52. Red blood cell transfusion.
    Becker GA; Aster RH
    Transfusion; 1973 Mar; 13(2):109-11. PubMed ID: 4695592
    [No Abstract]   [Full Text] [Related]  

  • 53. Transmission of rheumatoid arthritis through blood transfusion: a retrospective cohort study.
    Just SA; Rostgaard K; Titlestad K; Edgren G; Erikstrup C; Ullum H; Pedersen OB; Nielsen KR; Askling J; Lindegaard H; Hjalgrim H
    Ann Rheum Dis; 2018 Oct; 77(10):1536-1537. PubMed ID: 29496719
    [No Abstract]   [Full Text] [Related]  

  • 54. Blood safety in the developing world and WHO initiatives.
    Dhingra N
    Vox Sang; 2002 Aug; 83 Suppl 1():173-7. PubMed ID: 12617131
    [No Abstract]   [Full Text] [Related]  

  • 55. DELAYED HAEMOLYTIC TRANSFUSION REACTION CAUSED BY ANTI-C AND ANTI-E.
    JORGENSEN JR
    Dan Med Bull; 1964 Aug; 11():165-8. PubMed ID: 14176124
    [No Abstract]   [Full Text] [Related]  

  • 56. [Experimental research on hemato-medullary changes consequent to repeated transfusions of concentrated homologous erythrocytes in the albino rat].
    CORSO F
    Riv Emoter Immunoematol; 1959; 6():258-70. PubMed ID: 13812108
    [No Abstract]   [Full Text] [Related]  

  • 57. Risk management strategies for HIV in blood transfusion in developing countries.
    Bharucha ZS
    Vox Sang; 2002 Aug; 83 Suppl 1():167-71. PubMed ID: 12617130
    [No Abstract]   [Full Text] [Related]  

  • 58. Study of acute transfusion reactions in a teaching hospital of Sikkim: A hemovigilance initiative.
    Sharma DK; Datta S; Gupta A
    Indian J Pharmacol; 2015; 47(4):370-4. PubMed ID: 26285707
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Transfusion safety: state of the arts (ART)].
    Ben Romdhane N; Baccouche H; Mahjoub S; Khayati A
    Tunis Med; 2012 May; 90(5):357-61. PubMed ID: 22585641
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Blood use strategies in urologic surgery.
    Gilbert WB; Smith JA
    Urology; 2000 Apr; 55(4):461-7. PubMed ID: 10736484
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.